Cargando…
Molecular signatures of aggressive pediatric liver cancer
1. Conversion of tumor suppressor proteins (TSPs) by posttranslational modifications into oncogenes. 2. Activation of specific chromosomal regions, i.e., Aggressive Liver Cancer Domains (ALCDs) within many oncogenes, resulting in increased expression of oncogenes. 3. Potential epigenetic mechanisms...
Autores principales: | Johnston, Michael E., Timchenko, Nikolai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386353/ https://www.ncbi.nlm.nih.gov/pubmed/34447970 |
Ejemplares similares
-
HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer
por: Rivas, Maria, et al.
Publicado: (2021) -
Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer
por: D’Souza, Amber M., et al.
Publicado: (2022) -
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma
por: Gulati, Ruhi, et al.
Publicado: (2022) -
GSK3β and aging liver
por: Jin, Jingling, et al.
Publicado: (2009) -
Correction of aging phenotype in the liver
por: Rodriguez, Katherine, et al.
Publicado: (2018)